Cargando…

Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer

The landscape and characteristics of circulating exosomal messenger RNAs (emRNAs) are poorly understood, which hampered the accurate detection of circulating emRNAs. Through comparing RNA sequencing data of circulating exosomes with the corresponding data in tissues, we illustrated the different cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Jin, Chen, Rui, Zhao, Lin, Xu, Yalong, Cao, Zhi, Xu, Huan, Chen, Xi, Shi, Xiaolei, Zhu, Yasheng, Lyu, Ji, Jiang, Junfeng, Wang, Yue, Zhou, Tie, He, Jingyi, Wei, Xuedong, Wu, Jason Boyang, Yang, Bo, Wang, Fubo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008633/ https://www.ncbi.nlm.nih.gov/pubmed/33785037 http://dx.doi.org/10.1186/s12943-021-01349-z

Ejemplares similares

A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
por: Li, Yun, et al.
Publicado: (2021)

Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
por: Xu, Huan, et al.
Publicado: (2022)

Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma
por: He, Xing, et al.
Publicado: (2022)

Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population
por: Lyu, Ji, et al.
Publicado: (2019)

Prostatic Acid Phosphatase (PAP) Predicts Prostate Cancer Progress in a Population-Based Study: The Renewal of PAP?
por: Xu, Huan, et al.
Publicado: (2019)

Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience
por: Ji, Jin, et al.
Publicado: (2019)

FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer
por: Cao, Zhi, et al.
Publicado: (2021)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Autonomic nerve regulation for prostate cancer: study based on the tissue transcriptional analysis
por: Liu, Fang, et al.
Publicado: (2020)

The application of virtual reality training for anastomosis during robot-assisted radical prostatectomy
por: Wang, Fubo, et al.
Publicado: (2021)

Artificial intelligence for the diagnosis of clinically significant prostate cancer based on multimodal data: a multicenter study
por: Zhang, Huiyong, et al.
Publicado: (2023)

A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
por: Lai, Xianyin, et al.
Publicado: (2017)

Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
por: Zhao, An, et al.
Publicado: (2019)

Combined use of circulating tumor cells and salivary mRNA to detect non–small-cell lung cancer
por: Gu, Xianwen, et al.
Publicado: (2020)

ExosomePurity: tumour purity deconvolution in serum exosomes based on miRNA signatures
por: Wu, Tao, et al.
Publicado: (2023)

Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis
por: Cheng, Yang-Fan, et al.
Publicado: (2023)

The preoperative neutrophil‐to‐lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy
por: Cao, Zhi, et al.
Publicado: (2019)

Signature of Circulating MicroRNAs as Potential Biomarkers in Vulnerable Coronary Artery Disease
por: Ren, Jingyi, et al.
Publicado: (2013)

Oncogenic action of the exosome cofactor RBM7 by stabilization of CDK1 mRNA in breast cancer
por: Xi, Pei-Wen, et al.
Publicado: (2020)

Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy
por: Xu, Ji-Feng, et al.
Publicado: (2017)

Identification of lncRNA–miRNA–mRNA networks in circulating exosomes as potential biomarkers for systemic sclerosis
por: Sun, Xiaolin, et al.
Publicado: (2023)

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis
por: Wang, Yun, et al.
Publicado: (2021)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

Identification and evaluation of circulating exosomal miRNAs for the diagnosis of postmenopausal osteoporosis
por: Sun, Zhibang, et al.
Publicado: (2023)

Identification and Characterization of 293T Cell-Derived Exosomes by Profiling the Protein, mRNA and MicroRNA Components
por: Li, Jing, et al.
Publicado: (2016)

Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer
por: Wang, Fubo, et al.
Publicado: (2014)

A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study
por: Wu, Yixing, et al.
Publicado: (2021)

Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer
por: Yan, Shushan, et al.
Publicado: (2017)

A novel diagnostic signature based on three circulating exosomal mircoRNAs for chronic obstructive pulmonary disease
por: Shen, Yahui, et al.
Publicado: (2021)

Development of a 32-gene signature using machine learning for accurate prediction of inflammatory bowel disease
por: Yu, Shicheng, et al.
Publicado: (2023)

Exosomes as therapeutic vehicles in liver diseases
por: Ding, Jingyi, et al.
Publicado: (2021)

A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer
por: Guo, Ting, et al.
Publicado: (2022)

Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer
por: Shin, Sun, et al.
Publicado: (2021)

Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer
por: Wang, Jingyi, et al.
Publicado: (2021)

Genomic analysis of lncRNA and mRNA profiles in circulating exosomes of patients with rheumatic heart disease
por: Luo, Yanli, et al.
Publicado: (2019)

Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo
por: Greening, David W., et al.
Publicado: (2016)

Circulating exosomal hsa_circRNA_0039480 is highly expressed in gestational diabetes mellitus and may be served as a biomarker for early diagnosis of GDM
por: Jiang, Bao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ol94nhe7d8l7l5aa75vk2j07d